Adding Apalutamide to Perioperative ADT Associated with Better Outcomes of Radical Prostatectomy for High-Risk Localised or Locally Advanced Prostate Cancer By Ogkologos - June 3, 2026 256 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PROTEUS study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR NF1 Associated with More Cancer Types Than Previously Known April 20, 2021 HER2 Immunohistochemistry Testing May Not Be Needed in All Solid Tumours July 30, 2025 EMA Recommends Extension of Indications for Ribociclib to Include Use in... November 5, 2024 Encouraging Early Results Seen with Novel MEDI1191 in Advanced Tumours March 1, 2021 Load more HOT NEWS Cancer research in 2020: A spotlight on Manchester New on NCI’s Websites for September 2020 Five Questions With…Jae. The American Rescue Act: What You Need to Know
